Three more biotechs tum­ble on­to Wall Street to­day, rais­ing $475M as the IPO par­ty rocks on

It’s just an­oth­er day in the 2020 biotech IPO boom. Three went pub­lic this morn­ing and a fourth gained 75 per­cent on its Nas­daq trad­ing de­but.

Lead­ing the pack is the bi­o­log­i­cal an­a­lyt­ics-fo­cused com­pa­ny Berke­ley Lights, which priced at $22 per share and raised $178.2 mil­lion. Next up is ALX On­col­o­gy, which at $19 per share raised $161.5 mil­lion. Then comes T-cell biotech Pan­dion, re­vis­ing pre­vi­ous num­bers to $18 per share and of­fer­ing an up­sized 2 mil­lion more shares, rais­ing $135 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER